Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125090402 | 12509040 | 2 | F | 20160817 | 20160629 | 20160830 | EXP | 000654447 | CA-CONCORDIA PHARMACEUTICALS INC.-CO-PL-CA-2016-320 | CONCORDIA | 63.00 | YR | F | Y | 0.00000 | 20160829 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125090402 | 12509040 | 1 | PS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | U | 9768 | 400 | MG | QD | |||||||
| 125090402 | 12509040 | 2 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 0 | 20 | MG | |||||||||
| 125090402 | 12509040 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 0 | 50 | MG | /wk | ||||||||
| 125090402 | 12509040 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 20 | MG | /wk | ||||||||
| 125090402 | 12509040 | 5 | SS | ORENCIA | ABATACEPT | 1 | Unknown | 0 | |||||||||||
| 125090402 | 12509040 | 6 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 0 | 1 | G | BID | ||||||||
| 125090402 | 12509040 | 7 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
| 125090402 | 12509040 | 8 | C | XELJANZ | TOFACITINIB CITRATE | 1 | 0 | ||||||||||||
| 125090402 | 12509040 | 9 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | 0 | ||||||||||||
| 125090402 | 12509040 | 10 | C | HYDROMORPH CONTIN | HYDROMORPHONE | 1 | 0 | ||||||||||||
| 125090402 | 12509040 | 11 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125090402 | 12509040 | 1 | Product used for unknown indication |
| 125090402 | 12509040 | 2 | Product used for unknown indication |
| 125090402 | 12509040 | 3 | Rheumatoid arthritis |
| 125090402 | 12509040 | 4 | Rheumatoid arthritis |
| 125090402 | 12509040 | 5 | Product used for unknown indication |
| 125090402 | 12509040 | 6 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125090402 | 12509040 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125090402 | 12509040 | Arthropathy | |
| 125090402 | 12509040 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125090402 | 12509040 | 1 | 200709 | 200803 | 0 | |
| 125090402 | 12509040 | 2 | 200901 | 200912 | 0 | |
| 125090402 | 12509040 | 3 | 2010 | 0 | ||
| 125090402 | 12509040 | 4 | 200709 | 200803 | 0 | |
| 125090402 | 12509040 | 6 | 200709 | 200803 | 0 | |
| 125090402 | 12509040 | 8 | 20150401 | 0 |